Down-regulation of specific antigen-driven cytokine production in a population with endemic Schistosoma japonicum infection

Clinical and Experimental Immunology

Volumn 129, Issue 2, 2002, Pages 339-345

  Shen, L ^a   Zhang, Z S ^a   Wu, H W ^a   Weir, R E ^c   Xie, Z W ^b   Hu, L S ^b   Chen, S Z ^a   Ji, M J ^a   Su, C ^a   Zhang, Y ^c   Bickle, Q D ^c   Cousens, S N ^c   Taylor, M G ^a,c   Wu, G L ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Jiangxi Provincial Institute of Parasitic Diseases   (China)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Antibodies; Cytokines; Down regulation; Praziquantel; Schistosoma japonicum

Indexed keywords

ALLOANTIBODY; GAMMA INTERFERON; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G4 ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 5; PARASITE ANTIGEN; PRAZIQUANTEL; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ANTIGEN SPECIFICITY; ARTICLE; BLOOD CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENDEMIC DISEASE; FECES ANALYSIS; FEMALE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PARASITE CULTIVATION; PARASITE IDENTIFICATION; PRIORITY JOURNAL; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS; SCHOOL CHILD; SUPERNATANT;

ADOLESCENT; ADULT; ANIMALS; ANTHELMINTICS; ANTIBODIES, HELMINTH; ANTIBODY SPECIFICITY; ANTIGENS, HELMINTH; CHINA; CYTOKINES; DOWN-REGULATION; FEMALE; HUMANS; MALE; PRAZIQUANTEL; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS JAPONICA;

EID: 0036381747     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2002.01914.x     Document Type: Article

References (27)

1. Hagan P, Blumenthal UJ, Dunn D, Simpson AJ, Wilkins HA. Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature 1991; 349:243-5.
2. Dunne DW, Butterworth AE, Fulford AJ et al. Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection. Eur J Immunol 1992; 22:1483-94.
3. Demeure CE, Rihet P, Abel L, Ouattara M, Bourgois A, Dessein AJ. Resistance to Schistosoma mansoni in humans. influence of the IgE/IgG4 balance and IgG2 in immunity to reinfection after chemotherapy. J Infect Dis 1993; 168:1000-8.
4. Grogan JL, Kremsner PG, van Dam GJ, Metzger W, Mordmuller B, Deelder AM, Yazdanbakhsh M. Antischistosome IgG4 and IgE responses are affected differentially by chemotherapy in children versus adults. J Infect Dis 1996; 173:1242-7.
5. Webster M, Fallon PG, Fulford AJ, Butterworth AE, Ouma JH, Kimani G, Dunne DW. Effect of praziquantel and oxamniquine treatment on human isotype responses to Schistosoma mansoni: elevated IgE to adult worm. Parasite Immunol 1997; 19:333-5.
6. Webster M, Fallon PG, Fulford AJ, Butterworth AE, Ouma JH, Kimani G, Dunne DW. IgG4 and IgE responses to Schistosoma mansoni adult worms after treatment. J Infect Dis 1997; 175:493-4.
7. Zhang Z, Wu H, Chen S et al. Association between IgE antibody against soluble egg antigen and resistance to reinfection with Schistosoma japonicum. Trans Roy Soc Trop Med Hyg 1997; 91:606-8.
8. Ottesen EA, Hiatt RA, Cheever AW, Sotomayor ZR, Neva FA. The acquisition and loss of antigen-specific cellular immune responsiveness in acute and chronic schistosomiasis in man. Clin Exp Immunol 1978; 33:37-47.
9. Abdel-Salam E, Higashi GI, Kamal KA, Ishaac S. Cell-mediated immune assay in children with Schistosoma haematobium infection and the effect of niridazole therapy. Trans Roy Soc Trop Med Hyg 1981; 75:207-14.
10. Barsoum IS, Gamil FM, Al-Khafif MA, Ramzy RM, El Alamy MA, Colley DG. Immune responses and immunoregulation in relation to human schistosomiasis in Egypt. I. Effect of treatment on in vitro cellular responsiveness. Am J Trop Med Hyg 1982; 31:1181-7.
11. Colley DG, Barsoum IS, Dahawi HS, Gamil F, Habib M el Alamy MA. Immune responses and immunoregulation in relation to human schistosomiasis in Egypt. III. Immunity and longitudinal studies of in vitro responsiveness after treatment. Trans Roy Soc Trop Med Hyg 1986; 80:952-7.
12. Roberts M, Butterworth AE, Kimani G, Kamau T, Fulford AJ, Dunne DW, Ouma JH, Sturrock RF. Immunity after treatment of human schistosomiasis: association between cellular responses and resistance to reinfection. Infect Immun 1993; 61:4984-93.
13. Grogan JL, Kremsner PG, Deelder AM, Yazdanbakhsh M. Elevated proliferation and interleukin-4 release from CD4+ cells after chemotherapy in human Schistosoma haematobium infection. Eur J Immunol 1996; 26:1365-70.
14. Weir RE, Morgan AR, Britton WJ, Butlin CR, Dockrell HM. Development of a whole blood assay to measure T cell responses to leprosy: a new tool for immuno-epidemiological field studies of leprosy immunity. J Immunol Meth 1994; 176:93-101.
15. Kalckar HM. Differential spectrophotometry of purine compounds by means of specific enzymes. III. Studies of the enzymes of purine metabolism. J Biochem 1947; 167:461-5.
16. Wu HW, Luo JP, Wu GL. A method for the standardisation of OD value for the study of schistosome antibody with ELISA. Acta Parasitologica Med Entomologica Sinica 1995; 2:140-5.
17. King CL, Medhat A, Malhotra I et al. Cytokine control of parasite-specific anergy in human urinary schistosomiasis. IL-10 modulates lymphocyte reactivity. J Immunol 1996; 156:4715-21.
18. Montenegro SM, Miranda P, Mahanty S et al. Cytokine production in acute versus chronic human Schistosomiasis mansoni. the cross-regulatory role of interferon-gamma and interleukin-10 in the responses of peripheral blood mononuclear cells and splenocytes to parasite antigens. J Infect Dis 1999; 179:1502-14.
19. Doetze A, Satoguina J, Burchard G, Rau T, Loliger C, Fleischer B, Hoerauf A. Antigen-specific cellular hyporesponsiveness in a chronic human helminth infection is mediated by T (h) 3/T (r) 1-type cytokines IL-10 and transforming growth factor-beta but not by a T (h) 1 to T (h) 2 shift. Int Immunol 2000; 12:623-30.
20. Butterworth AE, Capron M, Cordingley JS et al. Immunity after treatment of human schistosomiasis mansoni. II. Identification of resistant individuals, and analysis of their immune responses. Trans Roy Soc Trop Med Hyg 1985; 79:393-408.
21. Correa-Oliveira R, Pearce EJ, Oliveira GC et al. The human immune response to defined immunogens of Schistosoma mansoni: elevated antibody levels to paramyosin in stool-negative individuals from two endemic areas in Brazil. Trans Roy Soc Trop Med Hyg 1989; 83:798-804.
22. Mutapi F, Ndhlovu PD, Hagan P, Spicer JT, Mduluza T, Turner CM, Chandiwana SK, Woolhouse ME. Chemotherapy accelerates the development of acquired immune responses to Schistosoma haematobium infection. J Infect Dis 1998; 178:289-93.
23. Woolhouse ME, Hagan P. Seeking the ghost of worms past. Nat Med 1999; 11:1225-7.
24. Li YS, Ross AG, Sleigh AC, Li Y, Waine GJ, Williams GJ, Tanner M, McManus DP. Antibody isotype responses, infection and re-infection for Schistosoma japonicum in a marshland area of China. Acta Trop 1999; 73:79-92.
25. Correa-Oliveira R, Rodrigues Caldas I, Assis Martins-Filho O et al. Analysis of the effects of treatment of human Schistosoma mansoni infection on the immune response of patients from endemic areas. Acta Trop 2000; 77:141-6.
26. Chen MG. Schistosoma japonicum and S. japonicum-like infections. epidemiology, clinical and pathological aspects. In: Jordan P, Webbe G, Sturrock R, eds. Human Schistosomiasis. Wallingford: CAB International, 1993:237-70.
27. Olveda RM, Daniel BL, Ramirez BD et al. Schistosomiasis japonica in the Philippines. the long-term impact of population-based chemotherapy on infection, transmission, and morbidity. J Infect Dis 1996; 174:163-72.